Thoracic transplantation

American Journal of Transplantation

Volumn 3, Issue SUPPL. 4, 2003, Pages 91-102

  Grover, Frederick L ^a   Barr, Mark L ^b   Edwards, Leah B ^c   Martinez, Fernando J ^d   Pierson III, Richard N ^e   Rosengard, Bruce R ^f   Murray, Susan ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNITED NETWORK FOR ORGAN SHARING   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Allocation policy; Deceased donors; Graft survival; Heart transplantation; Heart lung transplantation; Living donors; Lung transplantation; Organ donation; Patient survival; SRTR; Waiting list

Indexed keywords

AGE; BLOOD GROUP TYPING; CARDIOMYOPATHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONOLOGY; CONFERENCE PAPER; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; CYSTIC FIBROSIS; DATA ANALYSIS; EMPHYSEMA; ETHNOLOGY; GENDER; GRAFT SURVIVAL; HEALTH CARE POLICY; HEART DISEASE; HEART SURGERY; HEART TRANSPLANTATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LUNG DISEASE; LUNG TRANSPLANTATION; MEDICAL INFORMATICS; MEDICAL INFORMATION; MEDICAL PRACTICE; METHODOLOGY; ORGAN DONOR; OUTCOMES RESEARCH; POPULATION RESEARCH; RECIPIENT; REGISTRATION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SURGICAL MORTALITY; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; THORAX; TRANSPLANTATION; TREATMENT OUTCOME; UNITED STATES;

HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS;

EID: 0037737903     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.3.s4.9.x     Document Type: Conference Paper

References (28)

1. Dickinson DM, Ellison MD, Webb RL. Data sources and structure. Am J Transplant 2003; 3(Suppl. 4): 13-28.
2. Wolfe RA, Webb RL, Dickinson DM et al. Analytical approaches for transplant research. Am J Transplant 2003; 3(Suppl. 4): 103-113.
3. Kauffman MH, McBride MA, Shield CF, Daily OP, Wolf JS, Kirklin JK. Determinants of waiting time for heart transplants in the United States. J Heart Lung Transplant 1999; 18: 414-419.
4. Chen JM, Weinberg AD, Rose EA et al. Multivariate analysis of factors affecting waiting time to heart transplantation. Ann Thorac Surg 1996; 61: 570-575.
5. Morrow WE, Naftel D, Chinnock R et al. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group. J Heart Lung Transplant 1997; 16: 1255-1266.
6. Haywood GA, Rickenbacher PR, Trindade PT et al. Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria. Heart 1996; 75: 455-462.
7. Morley D, Brozena SC. Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation. Am J Cardiol 1994; 73: 379-383.
8. Lavee J, Kormos RL, Uretsky BF et al. Prediction of mortality in patients awaiting cardiac transplantation: increased risk of sudden death in ischemic compared to idiopathic dilated cardiomyopathy. Isr J Med Sci 1996; 32: 282-287.
9. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: Eighteenth Official Report - 2001. J Heart Lung Transplant 2001; 20: 805-815.
10. Boucek MM, Edwards LB, Keck BM et al. The Registry of the International Society for Heart and Lung Transplantation: Fifth Official Pediatric Report - 2001-2002. J Heart Lung Transplant 2002; 21: 827-840.
11. Augarten A, Hannah A, Aviram M et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplantation 2001; 5: 339-342.
12. Stern M, Reynaud-Gaubert M, Haloun A, Bertocchi M, Grenet D. Lung transplantation in cystic fibrosis. Patient selection criteria. Rev Malad Respir 2000; 17: 779-784.
13. Flaherty KR, White ES, Gay SE, Martinez FJ, Lynch JP. Timing of lung transplantation for patients with fibrotic lung diseases. Semin Respir Crit Care Med 2001; 22: 517-531.
14. Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001; 164: 103-108.
15. Arcasoy SM, Christie JD, Pochettino A et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001; 120: 873-880.
16. Liou TG, Adler FR, Cahill BC et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001; 286: 2683-2689.
17. Egan TM, Detterbeck FC, Mill MR et al. Improved results of lung transplantation for patients with cystic fibrosis. J Thorac Cardiovasc Surg 1995; 109: 224-235.
18. Maurer JR. Patient selection for lung transplantation. JAMA 2001; 286: 2720-2721.
19. De Meester J, Smits JMA, Persijn GG, Haverich A. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 1999; 18: 563-571.
20. De Meester J, Smits JMA, Persijn GG, Haverich A. Listing for lung transplantation life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplantation 2001; 20: 518-524.
21. King TE, Tooze JA, Schwartz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171-1181.
22. Organ Procurement and Transplantation Network Thoracic Organ Transplantation Committee Chaired by Frederick Grover. Report to the OPTN Board of Directors, June 28-29, 2001, San Diego.
23. Weill D, Kehsavjee S. Lung transplantation for emphysema: two lungs or one. J Heart Lung Transplant 2001; 20: 739-742.
24. Maurer J. Cystic fibrosis and bronchiectasis: selection, timing, and outcome. Sem Respir Crit Care Med 2001; 22: 499-508.
25. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001; 20: 935-941.
26. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: Eighteenth official report - 2001. J Heart Lung Transplant 2001; 20: 805-815.
27. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002; 21: 226-232.
28. Birkmeyer JD, Siewers AE, Finlayson EV et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137.